QR koda

Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease

BackgroundCachexia is associated with poor prognosis in chronic liver disease (CLD), yet robust predictors remain poorly defined. This study examined clinical factors and serum biomarkers associated with cachexia in patients with CLD.MethodsWe analyzed 356 of 526 patients with CLD who had complete c...

Popoln opis

Shranjeno v:
Principais autores: Takatsugu Tanaka, Goki Suda, Masatsugu Ohara, Osamu Maehara, Tomoka Yoda, Qingjie Fu, Zijian Yang, Naohiro Yasuura, Akimitsu Meno, Takashi Sasaki, Risako Kohya, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Takuya Sho, Shunsuke Ohnishi, Naoya Sakamoto
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2026-02-01
Serija:Frontiers in Nutrition
Teme:
biomarker
cachexia
chronic liver disease
fibroblast growth factor
liver cirrhosis
Online dostop:https://www.frontiersin.org/articles/10.3389/fnut.2026.1730695/full
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki